UNSPSC 51373452: Codeine/phenylephrine/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373452 Codeine/phenylephrine/pseudoephedrine is a Commodity code covering controlled and non-controlled pharmaceutical preparations used in state and local healthcare delivery, correctional health services, and community health initiatives. State and local governments procure these medications as components of broader pharmaceutical supply chains serving incarcerated populations, emergency medical services, and public health programs. The Washington State Department of Corrections RFQQ 13020 illustrates the scope: DOC is soliciting parenteral products and services including intravenous solutions, parenteral nutrition preparations, and controlled substances for medically necessary care to incarcerated individuals across eight correctional facilities, with bidders required to demonstrate experience preparing and delivering IV solutions and monitoring patient lab results. Issuing bodies include state corrections departments and county health agencies. The Washington procurement demonstrates state-level scale and multi-region contracting strategy, with DOC anticipating awards to up to three bidders per region across West, Central, and East divisions.

Recent activity spans Washington state and Florida. The Washington State Department of Corrections RFQ posted September 8, 2026 with response due October 7, 2026 at 4:00 PM PST, requiring PN bag delivery within 24 hours of order and other parenteral products within 8 hours, with contract term running November 26, 2026 through June 30, 2030 and fixed pricing for the initial two-year period. DOC set aspirational 5% Small and Diverse Business Goals and requires Subcontractor Inclusion Plans identifying minority-owned, women-owned, and disadvantaged businesses where feasible. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building. Both jurisdictions require commercial general liability and professional liability insurance; the Washington contract explicitly names the state as additional insured and mandates Washington State business licensure and NCIC clearance for all service personnel.